policy전자신문 IT (ETNews)· 7/12/2026, 7:00:00 AM8.0

Policy Blind Spot in 'Pharmaceutical Distribution IT Network'... Inter-Agency Ping-Pong Leaves Real-Time Tracking Void

Real-time tracking of pharmaceutical distribution processes is challenging due to inadequate coordination between government agencies. While private sector entities use IT systems to monitor drug pathways, health authorities only receive post-event data, creating institutional gaps. The lack of clear responsibility for managing pharmaceutical distribution processes has led to administrative shortcomings. Current regulations prevent regulatory agencies from accessing real-time temperature data during transportation, making it difficult to detect deviations that could compromise temperature-sensitive biologics. Despite this, no administrative penalties have been imposed on pharmaceutical companies for temperature deviations in the past three years. Inventory data managed by authorities is also inconsistent with on-the-ground realities due to fragmented data sources across three agencies.

💡 AI analysis: Fragmented inter-agency data flow leaves regulators blind to temperature deviations and counterfeit drugs, guaranteeing a rapid pivot toward mandatory centralized real-time tracking mandates and shifted supply-chain liability onto distributors.
View original (전자신문 IT (ETNews)) →
Policy Blind Spot in 'Pharmaceutical Distribution IT Network'... Inter-Agency Ping-Pong Leaves Real-Time Tracking Void | Forge Vector